Table of Content


COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Danaher Corporation - Key Company Facts 8
Danaher Corporation - Company Description 9
Danaher Corporation - Top Executives 10
Danaher Corporation- Top Executives Biographies 11
Danaher Corporation- Head Office & Locations 13
Head Office - Country 13
Key Subsidiaries 14
Key Joint Ventures 16
Danaher Corporation - Products and Services 17
Products 17
Services 18
Danaher Corporation - Historic Events 19
Danaher Corporation – Company’s Management Discussion 21
Danaher Corporation – Company’s Mission and Vision 29
Vision 29
Danaher Corporation - Corporate Strategy 30
Danaher Corporation - Business Description 33
Biotechnology 33
Life Sciences 34
Diagnostics 34
Danaher Corporation - ESG Spotlight 36
Environment 36
Social 37
Corporate Governance 37
Danaher Corporation - SWOT Analysis 39
Overview 39
Strengths 41
Weaknesses 44
Opportunities 46
Threats 47
Danaher Corporation – PESTLE Analysis 49
Overview 49
Political Factors 51
Economic Factors 52
Social Factors 54
Technological Factors 56
Legal Factors 57
Environmental Factors 59
Danaher Corporation - Financial Deep Dive 60
Share Price Trend - Nov-2023 to Nov-2024 (Average Share Closing Price) 60
Profit and Loss Statement 62
Summary of Profit and Loss Statement 62
Balance Sheet 64
Summary of Balance Sheet 64
Cash Flow Statement 66
Summary of Cash Flow Statement 66
Key Financial Ratio Analysis 68
Danaher Corporation - Ratio Charts 69
Activity Ratio Charts 69
Growth Ratios Charts 70
Leverage Ratio Charts 71
Liquidity Ratio Charts 72
Profitability Ratio Charts 73
Competing Players 74
Snapshot of Competing Players 75
Abbott Laboratories 75
Key Company Facts 75
Company Description 75
Becton, Dickinson and Company 76
Key Company Facts 76
Company Description 76
Boston Scientific Corporation 77
Key Company Facts 77
Company Description 77
Illumina Inc. 78
Key Company Facts 78
Company Description 78
Siemens Healthineers AG 79
Key Company Facts 79
Company Description 79
Thermo Fisher Scientific Inc. 80
Key Company Facts 80
Company Description 80
Danaher Corporation - In the News 81
22-Oct-2024 - Danaher Reports Third Quarter 2024 Results 81
19-Sep-2024 - Danaher Schedules Third Quarter 2024 Earnings Conference Call 83
10-Sep-2024 - Danaher Announces Quarterly Dividend 84
04-Sep-2024 - Danaher Confirms Third Quarter and Full Year 2024 Guidance 84
26-Aug-2024 - Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. 84
23-Jul-2024 - Danaher Reports Second Quarter 2024 Results 85
17-Jul-2024 - Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development 87
16-Jul-2024 - Danaher Releases 2024 Sustainability Report 89
19-Jun-2024 - Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics 91
05-Jun-2024 - Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer 92
23-Apr-2024 - Danaher Reports First Quarter 2024 Results 92
03-May-2023 - Danaher to present at bank of america securities health care conference 93
07-Mar-2023 - Danaher partners with the university of pennsylvania’s center for cellular immunotherapies to address manufacturing challenges impacting the uptake of cell therapies 94
08-Feb-2023 - Danaher announces new environmental and applied solutions company to be named veralto 95
10-Nov-2022 - Danaher launches beacon initiative and its first partnership focused on gene therapy innovation 96
14-Sep-2022 - Danaher announces intention to separate environmental & applied solutions segment to create an independent, publicly traded company 97
Danaher Corporation - Key Deals 98
11-Jul-2024 - Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening 98
06-Dec-2023 - Danaher Completes Acquisition of Abcam 99

31-Aug-2021 - Danaher Completes Acquisition of Aldevron 99
Appendix 100
Definitions 100
SWOT Analysis 100
PESTLE Analysis 100
Value Chain Analysis 100
ESG Spotlight 100
Financial Deep Dive 100
Financial Ratios - 101
Activity Ratios 101
Growth Ratios 102
Leverage Ratios 103
Liquidity Ratios 104
Market Ratios 105
Profitability Ratios 105
Research Methodology 106
Disclaimer 107
Contact Us 107



List of Figures

Charts

Figure 1: Danaher Corporation- SWOT Analysis 40
Figure 2: Danaher Corporation - PESTLE Analysis 50
Figure 3: Danaher Corporation - Average Share Price Trend - Nov-2023 to Nov-2024 61
Figure 4: Danaher Corporation - Profit and Loss Statement - 2020-2023 63
Figure 5: Danaher Corporation - Balance Sheet - 2020-2023 65
Figure 6: Danaher Corporation - Cash Flow Statement 2020-2023 67
Figure 7: Danaher Corporation - Activity Ratio Charts 69
Figure 8: Danaher Corporation - Growth Ratio Charts (Value %) 70
Figure 9: Danaher Corporation - Leverage Ratio Charts 71
Figure 10: Danaher Corporation - Liquidity Ratio Charts 72
Figure 11: Danaher Corporation - Profitability Ratio Charts (Value %) 73

List of Tables

Tables

Table 1: Danaher Corporation - Company Facts 8
Table 2: Danaher Corporation - Digital Presence 8
Table 3: Danaher Corporation - Top Executives 10
Table 4: Danaher Corporation - Top Executives Biographies 11
Table 5: Danaher Corporation - Subsidiaries 14
Table 6: Danaher Corporation - Key Joint Ventures 16
Table 7: Danaher Corporation - Products 17
Table 8: Danaher Corporation - Services 18
Table 9: Danaher Corporation - Historic Events 19
Table 10: Danaher Corporation - Share Price Trend - Nov-2023 to Nov-2024 60
Table 11: Danaher Corporation - Ratio Analysis - 2020-2023 68
Table 12: Danaher Corporation - Competing Players 74
Table 13: Competing Players - Abbott Laboratories - Key Company Facts 75
Table 14: Competing Players - Becton, Dickinson and Company - Key Company Facts 76
Table 15: Competing Players - Boston Scientific Corporation - Key Company Facts 77
Table 16: Competing Players - Illumina Inc. - Key Company Facts 78
Table 17: Competing Players - Siemens Healthineers AG - Key Company Facts 79
Table 18: Competing Players - Thermo Fisher Scientific Inc. - Key Company Facts 80